BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1394497)

  • 1. [Transdermal administration of estrogens in women with the postcastration and climacteric syndromes].
    Rotta L; Matĕchová E
    Cesk Gynekol; 1992 Sep; 57(7):336-40. PubMed ID: 1394497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [One-year follow-up of women treated with transdermal administration of estrogen for post-castration and climacteric syndromes].
    Rotta L; Matĕchová E
    Cesk Gynekol; 1992 Dec; 57(9-10):479-88. PubMed ID: 1291124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transdermal estradiol in the prevention of the menopause-induced increase in osteoresorption].
    Stĕpán J; Pospíchal J; Formánková J; Rosenová Z; Kanka J; Mensík J; Presl J; Pacovský V
    Cesk Gynekol; 1989 Aug; 54(7):496-505. PubMed ID: 2805095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy and the estraderm transdermal system.
    Youngkin EQ
    Nurse Pract; 1990 May; 15(5):19-26, 31. PubMed ID: 2342664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H; Heytmanek H; Kurz C; Metka M
    Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints].
    Tsvetkov Ts; Tsvetkov K; Petkova U
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systen--transdermal estradiol for substitution following surgical menopause].
    Rachev E; Karag'ozov I
    Akush Ginekol (Sofiia); 1995; 34(3):74-6. PubMed ID: 8743861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised study to compare the efficacy and safety of new 17 beta-oestradiol transdermal matrix patch with Estraderm TTS 50 in hysterectomised postmenopausal women. The Lyrelle Study Group.
    al-Azzawi F; Van der Mooren MJ; Rolland R; Hirvonen E
    Br J Clin Pract; 1997; 51(1):20-3, 25-6. PubMed ID: 9158267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An efficacy and tolerance study of transdermal estrogen replacement therapy with the preparation Systen R50 (Cilag)].
    Tanchev S; Moskova P
    Akush Ginekol (Sofiia); 1995; 34(2):65-7. PubMed ID: 8651434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of early initiated oestrogen replacement therapy on plasma homocysteine levels in women in surgically induced menopause.
    Yüksel H; Cobanoğlu M; Odabaşi AR; Sezer SD; Küçük M; Serter M
    Gynecol Endocrinol; 2011 Feb; 27(2):101-6. PubMed ID: 20504097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Percutaneous estrogen therapy in the post-menopausal period].
    Keller PJ
    Schweiz Med Wochenschr; 1989 Jul; 119(29):999-1004. PubMed ID: 2678438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). I. Tolerability, adhesion and efficacy.
    Rozenbaum H; Birkhäuser M; De Nooyer C; Lambotte R; Pornel B; Schneider H; Studd J
    Maturitas; 1996 Nov; 25(3):161-73. PubMed ID: 8981333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
    Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low-dose estrogens in the treatment of the climacteric syndrome].
    Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
    Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). II. Local skin tolerability.
    Rozenbaum H; Birkhäuser M; De Nooyer C; Lambotte R; Pornel B; Schneider H; Studd J; Thebault J
    Maturitas; 1996 Nov; 25(3):175-85. PubMed ID: 8981334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transdermal estrogen treatment. A placebo controlled study].
    Iversen OE; Eid AB; Johannesen KH; Nyland B; Løvset T
    Tidsskr Nor Laegeforen; 1991 Aug; 111(20):2544-6. PubMed ID: 1948834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
    Prázný M; Fait T; Vrablik M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative multicenter study of two transdermal estradiol replacement therapies in the treatment of postmenopausal symptoms.
    Van Leusden HA; Albertyn G; Verlaine C; Van Ruymbeke J
    Int J Fertil Menopausal Stud; 1993; 38(4):210-8. PubMed ID: 8401679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.